Long-term outcome of neonatal meningitis.

OBJECTIVE To determine the long-term outcome of neonatal bacterial meningitis and the relationship between the outcome and specific features in the acute stage of the disease; and to compare the outcome between infants with neonatal meningitis and high-risk infants without meningitis. DESIGN Prospective clinical evaluations of 21 survivors of meningitis and 21 matched controls who were retrospectively selected from a high-risk patient population. SETTING Program of follow-up performed at the Children and Youth Project's High Risk Center of the Department of Pediatrics, University of Louisville, Louisville, Ky. Neonates were inborn at a university hospital with a high-risk obstetric unit and level III nursery. PATIENTS Twenty-six consecutive neonates born between 1970 and 1980 with culture-proven bacterial meningitis, excluding neonates with congenital neurologic defects. Nineteen of 21 survivors and 21 controls matched by age, sex, race, birth weight, and gestational age were followed up from 1 to 14 years (mean, 7.8 years). Both survivors and controls fell below the federal poverty guidelines. RESULTS Gram-positive meningitis was twice as common as gram-negative meningitis with co-occurrence of meningitis and sepsis in half of the cases. Neonates with gram-positive meningitis and higher birth weight had a higher survival rate, but this finding was not statistically significant. The mortality rate in neonates with gram-negative meningitis was almost three times higher than that of neonates with gram-positive meningitis, but no significant difference was observed between their morbidity rates. Eight (38%) of 21 survivors were normal, while another eight (38%) and five (24%) had mild and moderate to severe sequelae, respectively. Survivors of meningitis had lower IQ scores and more severe sequelae than matched controls. CONCLUSION Neonatal bacterial meningitis results in poorer long-term outcome than in controls, but improved outcome compared with previous studies of neonatal meningitis.

[1]  H. Halliday,et al.  Meningitis in the newborn--a 14 year review. , 1989, Archives of disease in childhood.

[2]  A. Okolo,et al.  Neonatal Meningitis in Nigerian Infants , 1984, Acta paediatrica Scandinavica.

[3]  H. Zanen,et al.  Neonatal group B streptococcal meningitis. , 1984, Archives of disease in childhood.

[4]  B. Macarthur,et al.  Escherichia coli meningitis in the newborn: follow-up study. , 1978, The New Zealand medical journal.

[5]  R. Bortolussi,et al.  Prognosis for survival in neonatal meningitis: clinical and pathologic review of 52 cases. , 1978, Canadian Medical Association journal.

[6]  James R. Allen,et al.  The Sequelae of Group B β-Hemolytic Streptococcal Meningitis in Early Infancy , 1977 .

[7]  J. Heckmatt Coliform meningitis in the newborn. , 1976, Lancet.

[8]  S. Mize,et al.  A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group. , 1976, The Journal of pediatrics.

[9]  M. Kazemi,et al.  Long‐term Sequelae of Neonatal Meningitis , 1974, Developmental medicine and child neurology.

[10]  F. Barrett,et al.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. , 1973, The Journal of pediatrics.

[11]  R. Mcdonald Purulent meningitis in newborn babies: observations and comments based on a series of 82 patients. , 1972, Clinical pediatrics.

[12]  J. Overall,et al.  Neonatal bacterial meningitis. Analysis of predisposing factors and outcome compared with matched control subjects. , 1970, The Journal of pediatrics.

[13]  B. Landing,et al.  Purulent meningitis of newborn infants. Eleven-year experience in the antibiotic era. , 1961, The New England journal of medicine.